HIV treatment as prevention: to be or not to be?

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 20798638)

Published in J Acquir Immune Defic Syndr on October 01, 2010

Authors

Myron S Cohen

Articles by these authors

(truncated to the top 100)

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60

The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol (2004) 7.04

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med (2009) 6.22

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85

Syphilis in China: results of a national surveillance programme. Lancet (2007) 5.76

Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA (2004) 5.66

Population-based study of chlamydial infection in China: a hidden epidemic. JAMA (2003) 5.40

Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet (2011) 5.34

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS (2007) 4.89

HIV/AIDS risk among brothel-based female sex workers in China: assessing the terms, content, and knowledge of sex work. Sex Transm Dis (2004) 4.88

AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science (2005) 4.44

HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23

Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis (2011) 3.78

Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog (2010) 3.68

Surplus men, sex work, and the spread of HIV in China. AIDS (2005) 3.64

HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis (2006) 3.17

Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis (2011) 3.16

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10

HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr (2011) 2.49

Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44

Frequent detection of acute primary HIV infection in men in Malawi. AIDS (2004) 2.43

The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis (2005) 2.31

Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis (2006) 2.31

Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest (2004) 2.30

Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A (2012) 2.27

China's syphilis epidemic: a systematic review of seroprevalence studies. Sex Transm Dis (2006) 2.23

Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health (2006) 2.17

Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis (2010) 2.13

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11

Keep them in school: the importance of education as a protective factor against HIV infection among young South African women. Int J Epidemiol (2008) 2.00

Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95

Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS (2007) 1.89

HIV incidence among men who have sex with men in China: a meta-analysis of published studies. PLoS One (2011) 1.79

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis (2013) 1.77

Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS (2012) 1.73

Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis (2011) 1.70

Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost? Clin Infect Dis (2011) 1.68

Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol (2002) 1.58

Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog (2011) 1.57

Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology (2013) 1.55

The pharmacokinetics and viral activity of tenofovir in the male genital tract. J Acquir Immune Defic Syndr (2008) 1.55

HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med (2012) 1.55

Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis (2004) 1.54

Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis (2003) 1.52

China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses. Curr Opin Infect Dis (2011) 1.52

Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput Biol (2010) 1.51

HIV-1 Populations in Semen Arise through Multiple Mechanisms. PLoS Pathog (2010) 1.47

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women. J Acquir Immune Defic Syndr (2004) 1.45

Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis (2013) 1.43

Factors related to female sex workers' willingness to utilize VCT service: a qualitative study in Jinan city, northern China. AIDS Behav (2008) 1.42

Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention. AIDS Behav (2011) 1.41

Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol (2003) 1.34

Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol (2006) 1.33

Preexposure prophylaxis for HIV--where do we go from here? N Engl J Med (2012) 1.33

Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples. Contemp Clin Trials (2012) 1.33

Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS (2011) 1.33

Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis (2002) 1.33

Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One (2011) 1.32

Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis (2005) 1.31

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J Virol (2011) 1.28

Policies and politics that promote HIV infection in the Southern United States. AIDS (2014) 1.28

Highly efficient HIV transmission to young women in South Africa. AIDS (2007) 1.28

An expanding syphilis epidemic in China: epidemiology, behavioural risk and control strategies with a focus on low-tier female sex workers and men who have sex with men. Sex Transm Infect (2011) 1.26

Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC. Front Microbiol (2011) 1.26

Risk of syphilis in STI clinic patients: a cross-sectional study of 11,500 cases in Guangxi, China. Sex Transm Infect (2007) 1.25

A twin response to twin epidemics: integrated HIV/syphilis testing at STI clinics in South China. J Acquir Immune Defic Syndr (2011) 1.24

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.23

Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J Virol (2011) 1.21

Does ART prevent HIV transmission among MSM? AIDS (2012) 1.20

Detection of Acute and Established HIV Infections in Sexually Transmitted Disease Clinics in Guangxi, China: Implications for Screening and Prevention of HIV Infection. J Infect Dis (2007) 1.19

Sexually transmitted infections among individuals over fifty years of age in China. AIDS Patient Care STDS (2010) 1.19

How can we better identify early HIV infections? Curr Opin HIV AIDS (2015) 1.18

Factors associated with utilization of a free HIV VCT clinic by female sex workers in Jinan City, Northern China. AIDS Behav (2011) 1.17

Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. AIDS (2011) 1.16

Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Sex Transm Dis (2010) 1.15

A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia. J Infect Dis (2010) 1.15

Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. J Virol (2013) 1.15

Integrated syphilis/HIV screening in China: a qualitative analysis. BMC Health Serv Res (2010) 1.14

Investigating a sexual network of black men who have sex with men: implications for transmission and prevention of HIV infection in the United States. J Acquir Immune Defic Syndr (2012) 1.14

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells. J Clin Invest (2015) 1.13

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication. J Virol (2012) 1.13

HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr (2013) 1.11

Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis (2010) 1.11

Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure. AIDS (2013) 1.08

Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr (2013) 1.07

Scaling up syphilis testing in China: implementation beyond the clinic. Bull World Health Organ (2010) 1.07

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men. J Infect Dis (2002) 1.07

HIV-1 populations in blood and breast milk are similar. Virology (2004) 1.06

HIV treatment as prevention and "the Swiss statement": in for a dime, in for a dollar? Clin Infect Dis (2010) 1.06

HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. J Infect Dis (2007) 1.05

HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. PLoS One (2013) 1.04

Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest? J Acquir Immune Defic Syndr (2014) 1.03

Advances in HIV prevention for serodiscordant couples. Curr HIV/AIDS Rep (2014) 1.02